FollowMyHealth Patient Portal

Jeff M. Michalski, MD, MBA

Professor, Radiation Oncology
Vice Chairman, Radiation Oncology
Chief, Genitourinary Service

Specialty Areas

Radiation Oncology
Genitourinary Oncology
Sarcoma
Prostate Cancer
Intensity Modulated Radiation Therapy ( IMRT)
Pediatric Radiation Oncology

Board Certifications

Radiation Oncology

Hospital Affiliations

Barnes-Jewish Hospital
St. Louis Children's Hospital
Christian Hospital
Barnes-Jewish West County Hospital
VA Medical Center - St. Louis - John Cochran Division

Areas of Clinical Interest

Radiation therapy, radiation oncology, pediatric oncology, prostate conditions, prostate cancer, treatment planning, carcinoma of the prostate, conformal radiation therapy, prostate brachytherapy

  • Maps & Directions
  • Education
  • Publication & Research

Maps & Directions

Maps & Directions

Center for Advanced Medicine
Siteman Cancer Center

4921 Parkview Place
St. Louis, MO 63110
Phone: 314-747-7222

Floor: LL
Office Phone: 314-747-7236
Fax: 314-747-9557

Christian Hospital

1133 Dunn Road
St. Louis, MO 63136

Office Phone: 314-653-5255
Fax: 314-653-4283

Siteman Cancer Center - South County

5225 MidAmerica Plaza
St. Louis, MO 63129
Phone: 314-747-7222

Education

Education

Instructor - Fellow: Washington University School of Medicine, Radiation Oncology Center, St. Louis, MO 1991
Resident: Radiation Oncology, Washington University School of Medicine, St. Louis, MO. 1990
Resident: Radiation Oncology, Columbia-Presbyterian Medical Center 1988
Medical Degree: Medical College Of Wisconsin 1986
B.S. Biochemistry: University of Wisconsin-Madison 1982

Publication & Research

Publication & Research

Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.
Luh JY, Finkelstein SE, Michalski JM, Md HS
Ann Intern Med. 2018 Apr 17; 168(8)607-608. doi: 10.7326/L17-0734.

PMID:
    29677258
    [PubMed - in process]
Related citations


Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial.
Michalski JM, Moughan J, Purdy J, Bosch W, Bruner DW, Bahary JP, Lau H, Duclos M, Parliament M, Morton G, Hamstra D, Seider M, Lock MI, Patel M, Gay H, Vigneault E, Winter K, Sandler H
JAMA Oncol. 2018 Mar 15; doi: 10.1001/jamaoncol.2018.0039.

PMID:
    29543933
    [PubMed - as supplied by publisher]
Related citations


Association of 1p/19q Codeletion and Radiation Necrosis in Adult Cranial Gliomas After Proton or Photon Therapy.
Acharya S, Robinson CG, Michalski JM, Mullen D, DeWees TA, Campian JL, Chundury A, Bottani B, Hallahan DE, Bradley JD, Huang J
Int J Radiat Oncol Biol Phys. 2018 Feb 9; pii: S0360-3016(18)30223-2. doi: 10.1016/j.ijrobp.2018.01.099.

PMID:
    29534896
    [PubMed - as supplied by publisher]
Related citations


NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients.
Ali AN, Zhang P, Yung WKA, Chen Y, Movsas B, Urtasun RC, Jones CU, Choi KN, Michalski JM, Fischbach AJ, Markoe AM, Schultz CJ, Penas-Prado M, Garg MK, Hartford AC, Kim HE, Won M, Curran WJ Jr
J Neurooncol. 2018 Mar; 137(1)39-47. doi: 10.1007/s11060-017-2558-x.

PMID:
    29404979
    [PubMed - in process]
Related citations


Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features.
Hwang WL, Tendulkar RD, Niemierko A, Agrawal S, Stephans KL, Spratt DE, Hearn JW, Koontz BF, Lee WR, Michalski JM, Pisansky TM, Liauw SL, Abramowitz MC, Pollack A, Moghanaki D, Anscher MS, Den RB, Zietman AL, Stephenson AJ, Efstathiou JA
JAMA Oncol. 2018 Jan 25; e175230. doi: 10.1001/jamaoncol.2017.5230.

PMID:
    29372236
    [PubMed - as supplied by publisher]
Related citations


A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of life.
Jackson WC, Dess RT, Litzenberg DW, Li P, Schipper M, Rosenthal SA, Chang GC, Horwitz EM, Price RA, Michalski JM, Gay HA, Wei JT, Feng M, Feng FY, Sandler HM, Wallace RE, Spratt DE, Hamstra DA
Pract Radiat Oncol. 2018 Jan - Feb; 8(1)40-47. doi: 10.1016/j.prro.2017.08.004.

PMID:
    29304991
    [PubMed - in process]
Related citations


Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate Cancer.
Ramey SJ, Agrawal S, Abramowitz MC, Moghanaki D, Pisansky TM, Efstathiou JA, Michalski JM, Spratt DE, Hearn JWD, Koontz BF, Liauw SL, Pollack A, Anscher MS, Den RB, Stephans KL, Zietman AL, Lee WR, Stephenson AJ, Tendulkar RD
Eur Urol. 2017 Nov 9; pii: S0302-2838(17)30900-4. doi: 10.1016/j.eururo.2017.10.009.

PMID:
    29128208
    [PubMed - as supplied by publisher]
Related citations


Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the Bladder.
Fischer-Valuck BW, Rao YJ, Henke LE, Rudra S, Hui C, Baumann BC, Gay HA, Michalski JM
Eur Urol Focus. 2017 Sep 14; pii: S2405-4569(17)30205-5. doi: 10.1016/j.euf.2017.09.001.

PMID:
    28919521
    [PubMed - as supplied by publisher]
Related citations


Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: American Urological Association/American Society of Clinical Oncology/American Society for Radiation Oncology/Society of Urologic Oncology Clinical Practice Guideline Summary.
Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP, Lotan Y, Meeks JJ, Michalski JM, Morgan TM, Quale DZ, Rosenberg JE, Zietman AL, Holzbeierlein JM
J Oncol Pract. 2017 Sep; 13(9)621-625. doi: 10.1200/JOP.2017.024919.

PMID:
    28796558
    [PubMed - in process]
Related citations


Thrombotic Thrombocytopenic Purpura (TTP)
Stanley M, Michalski JM
. 2018 Jan;

PMID:
    28613472
    [PubMed]
Related citations


External Beam Radiation Therapy or Brachytherapy With or Without Short-course Neoadjuvant Androgen Deprivation Therapy: Results of a Multicenter, Prospective Study of Quality of Life.
Gay HA, Sanda MG, Liu J, Wu N, Hamstra DA, Wei JT, Dunn RL, Klein EA, Sandler HM, Saigal CS, Litwin MS, Kuban DA, Hembroff L, Regan MM, Chang P, Prostate Cancer Outcomes and Satisfaction with Treatment Quality Assessment Consortium., Michalski JM
Int J Radiat Oncol Biol Phys. 2017 Jun 1; 98(2)304-317. doi: 10.1016/j.ijrobp.2017.02.019.

PMID:
    28463150
    [PubMed - indexed for MEDLINE]
Related citations


Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.
Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP, Lotan Y, Meeks JJ, Michalski JM, Morgan TM, Quale DZ, Rosenberg JE, Zietman AL, Holzbeierlein JM
J Urol. 2017 Sep; 198(3)552-559. doi: 10.1016/j.juro.2017.04.086.

PMID:
    28456635
    [PubMed - in process]
Related citations


Adjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621.
Hurwitz MD, Harris J, Sartor O, Xiao Y, Shayegan B, Sperduto PW, Badiozamani KR, Lawton CAF, Horwitz EM, Michalski JM, Roof K, Beyer DC, Zhang Q, Sandler HM
Cancer. 2017 Jul 1; 123(13)2489-2496. doi: 10.1002/cncr.30620.

PMID:
    28323339
    [PubMed - indexed for MEDLINE]
Related citations


Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal Bleeding.
Lee JY, Daignault-Newton S, Heath G, Scarlett S, Sanda MG, Chang P, Regan MM, Michalski JM, Sandler HM, Feng FY, Kuban DA, Zietman AL, Ciezki JP, Kaplan ID, Crociani C, McLaughlin WP, Mantz CA, Finkelstein SE, Suy S, Collins SP, Garin O, Ferrer M, Hamstra DA, Spratt DE
Int J Radiat Oncol Biol Phys. 2016 Nov 15; 96(4)770-777. doi: 10.1016/j.ijrobp.2016.07.038.

PMID:
    27663760
    [PubMed - indexed for MEDLINE]
Related citations


Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy-A Multi-Institutional Observational Study.
Pisansky TM, Agrawal S, Hamstra DA, Koontz BF, Liauw SL, Efstathiou JA, Michalski JM, Feng FY, Abramowitz MC, Pollack A, Anscher MS, Moghanaki D, Den RB, Stephans KL, Zietman AL, Lee WR, Kattan MW, Stephenson AJ, Tendulkar RD
Int J Radiat Oncol Biol Phys. 2016 Dec 1; 96(5)1046-1053. doi: 10.1016/j.ijrobp.2016.08.043.

PMID:
    27745980
    [PubMed - indexed for MEDLINE]
Related citations


Hematologic Safety of Radium-223 Dichloride: Baseline Prognostic Factors Associated With Myelosuppression in the ALSYMPCA Trial.
Vogelzang NJ, Coleman RE, Michalski JM, Nilsson S, O'Sullivan JM, Parker C, Widmark A, Thuresson M, Xu L, Germino J, Sartor O
Clin Genitourin Cancer. 2017 Feb; 15(1)42-52.e8. doi: 10.1016/j.clgc.2016.07.027.

PMID:
    27613490
    [PubMed - indexed for MEDLINE]
Related citations


Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment.
Chang P, Regan MM, Ferrer M, Guedea F, Patil D, Wei JT, Hembroff LA, Michalski JM, Saigal CS, Litwin MS, Hamstra DA, Kaplan ID, Ciezki JP, Klein EA, Kibel AS, Sandler HM, Dunn RL, Crociani CM, Sanda MG, PROST-QA Consortium.
J Urol. 2017 Feb; 197(2)376-384. doi: 10.1016/j.juro.2016.08.101.

PMID:
    27593476
    [PubMed - in process]
Related citations


Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy.
Tendulkar RD, Agrawal S, Gao T, Efstathiou JA, Pisansky TM, Michalski JM, Koontz BF, Hamstra DA, Feng FY, Liauw SL, Abramowitz MC, Pollack A, Anscher MS, Moghanaki D, Den RB, Stephans KL, Zietman AL, Lee WR, Kattan MW, Stephenson AJ
J Clin Oncol. 2016 Aug 15; pii: JCO679647.

PMID:
    27528718
    [PubMed - as supplied by publisher]
Related citations


A comparative study based on image quality and clinical task performance for CT reconstruction algorithms in radiotherapy.
Li H, Dolly S, Chen HC, Anastasio MA, Low DA, Li HH, Michalski JM, Thorstad WL, Gay H, Mutic S
J Appl Clin Med Phys. 2016 Jul 8; 17(4)377-390. doi: 10.1120/jacmp.v17i4.5763.

PMID:
    27455472
    [PubMed - indexed for MEDLINE]
Related citations


Efficacy and Safety of Radium-223 Dichloride in Symptomatic Castration-resistant Prostate Cancer Patients With or Without Baseline Opioid Use From the Phase 3 ALSYMPCA Trial.
Parker C, Finkelstein SE, Michalski JM, O'Sullivan JM, Bruland Ø, Vogelzang NJ, Coleman RE, Nilsson S, Sartor O, Li R, Seger MA, Bottomley D
Eur Urol. 2016 Nov; 70(5)875-883. doi: 10.1016/j.eururo.2016.06.002.

PMID:
    27344296
    [PubMed - indexed for MEDLINE]
Related citations